AP NEWS

Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2019 - ResearchAndMarkets.com

January 25, 2019

DUBLIN--(BUSINESS WIRE)--Jan 25, 2019--The “Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2019 offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Guanylate Cyclase-Coupled Receptor Activators development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

Clinical Non-clinical Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Companies Featured

Allergan Astellas Pharma AstraZeneca Ironwood Pharmaceuticals Callisto Pharmaceuticals Mayo Clinic Palatin Technologies BIND Therapeutics

Topics Covered

1. Report Introduction

2. Guanylate Cyclase-Coupled Receptor Activators - Overview

3. Pipeline Therapeutics

An Overview of Pipeline Products for Guanylate Cyclase-Coupled Receptor Activators

4. Comparative Analysis

5. Guanylate Cyclase-Coupled Receptor Activators Pipeline Products in Clinical Stages

5.1 Drug Name : Company Name

Product Description Research and Development Product Development Activities

6. Guanylate Cyclase-Coupled Receptor Activators Pipeline Products in Non-clinical Stages

6.1 Drug Name : Company Name

Product Description Research and Development Product Development Activities

7. Therapeutic Assessment: Active Products

Pipeline Assessment by Route of Administration Pipeline Assessment by Stage and Route of Administration Pipeline Assessment by Molecule Type Pipeline Assessment by Stage and Molecule Type

8. Inactive Pipeline Products

8.1 Drug Name : Company Name

Product Description Research and Development Product Development Activities Reason for dormancy/discontinuation

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/x48qlv/guanylate?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190125005192/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Enzymes

KEYWORD:

INDUSTRY KEYWORD: MANUFACTURING CHEMICALS/PLASTICS

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/25/2019 07:46 AM/DISC: 01/25/2019 07:46 AM

http://www.businesswire.com/news/home/20190125005192/en

AP RADIO
Update hourly